Effects of apomorphine and L‐dopa on the parkinsonian bladder
- 1 January 1993
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 12 (3) , 203-209
- https://doi.org/10.1002/nau.1930120302
Abstract
Neurogenic bladder frequently occurs in Parkinson's disease. Detrusor hyperreflexia is a consequence of nigrostriatal dopamine depletion, whereas the cause of hyporeflexia remains unclear. We compared the results of cystometry and urethral profilometry with and without apomorphine (and L dopa) in 12 idiopathic parkinsonians with urinary disorders free of dopaminergic treatment. Whereas hyperreflexic patients improved with apomorphine, and to a lesser extent with L dopa, these drugs had no effect on hyporeflexic patients. These results confirm the role of dopaminergic lesions in the occurrence of bladder hyperreflexia and the possible implication of nondopaminergic lesions in the occurrence of hyporeflexia.Keywords
This publication has 9 references indexed in Scilit:
- Urinary incontinence in female Parkinson disease patients: Pitfalls of DiagnosisUrology, 1989
- ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTIONThe Lancet, 1988
- Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuroscience Letters, 1988
- Contraction of Urinary Bladder by Central Norepinephrine Originating in the Locus CoeruleusJournal of Urology, 1988
- Locus coeruleus neurons and sympathetic nerves: Activation by visceral afferentsBrain Research, 1986
- Detrusor properties related to prostatismNeurourology and Urodynamics, 1986
- Micturition Disturbance in Parkinson's DiseaseBritish Journal of Urology, 1985
- Effect of levodopa on urinary bladderUrology, 1976
- Effects of Levodopa on the Bladder OutletJournal of Urology, 1975